| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Wednesday, January 30, 2019 Roche has stopped a pair of phase 3 Alzheimer’s disease trials after an interim analysis found they were unlikely to hit their primary endpoint. The setback wipes out near-term hopes of getting the AC Immune-partnered anti-Abeta antibody crenezumab to market. |
|
|
Top Stories Of The Week Friday, January 25, 2019 The mass exodus from AbbVie's Humira to biosimilars confirms what AbbVie’s executives have already admitted, which is that their initial estimate of a 20% revenue loss in Europe by 2020 was way too optimistic. Tuesday, January 29, 2019 Celgene has signed on to a deal worth about $1 billion for a Canadian preclinical asset: a first-in-class small molecule that targets protein-protein interactions and epigenetic regulation in leukemia and lymphoma. Monday, January 28, 2019 Amgen may have the first-mover advantage in the new class of CGRP migraine prevention drugs, but the company didn't get top billing with one major pharmacy benefits manager. CVS gave that to Teva and Eli Lilly instead. Tuesday, January 29, 2019 It’s no secret Sanofi has had trouble with its world-first dengue vaccine, Dengvaxia, but that hasn't dissuaded Takeda. Its own dengue shot met its goal in a pivotal phase 3 study that covered eight countries and more than 20,000 participants. Monday, January 28, 2019 Medtronic has moved to acquire EPIX Therapeutics and its catheter-based cardiac ablation system with plans to offer it alongside its own products and build out what the company describes as a “comprehensive suite of tools” for treating heart arrhythmias, including atrial fibrillation. Monday, January 28, 2019 The flu virus' ability to rapidly mutate into vaccine-resistant strains has made the search for a universal vaccine all the more challenging. Researchers from the National Institutes of Health have found a new clue to providing broad-based protection against the flu—and it rests partly on Roche’s FDA-approved remedy Tamiflu. Monday, January 28, 2019 Allergan’s crowd of fat-freezing celebrities just gained a Real Housewife. Sonja Morgan, one of the cast members of the Bravo series in New York City, is the face of the company's new “Let’s Get Real About Self-Care” promo for fat-freezing treatment CoolSculpting. Tuesday, January 29, 2019 The FDA in 2017 ripped Indian drugmaker Lupin in a warning letter for not learning from past mistakes. In a new visit to one of the two plants cited in that letter, the FDA has again found issues. Thursday, January 31, 2019 U.K. life sciences company Abcam has expanded its presence in rabbit monoclonal antibodies with the acquisition of California’s Calico Biolabs for an undisclosed price. Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: Oracle Health Sciences 92% of survey respondents make changes to their RTSM/IRT systems due to study changes. See what else puts a strain on their clinical trials. Download the Research Whitepaper. Sponsored by: Patheon, part of Thermo Fisher Scientific Download this whitepaper to learn more. Sponsored by: BioAnalytix, Inc. This whitepaper reviews fundamental aspects of HCPs that pertain to biologic drug development and presents current and emerging approaches to HCP analysis. Sponsored by: The Kinetix Group Explore how the pharma industry can adapt its approach to the changing healthcare marketplace in the era of the Quadruple Aim Sponsored by: Veradigm Clinical trials take too long and cost too much—here's what needs to change. Sponsored by: AlphaSense It’s never been more challenging to stay on top of competitive factors impacting your industry. Discover how AI can help competitive teams achieve more proactive market intelligence. Sponsored by: Reprints Desk, Inc. Go from Search to Full-Text Scientific Papers in a Single Click! Sponsored by: Blue Latitude Health This white paper consists of original data and expert interviews. Download it today for exclusive tools, tips and analysis on achieving launch excellence in challenging pharma markets. Sponsored by: DeciBio Consulting With the liquid biopsy market maturing and >80 companies still competing with liquid biopsy offerings, it is crucial for investors to be able to cut through the noise and identify the winners. Presented by: Aprecia Get ahead of looming challenges in the market that include both generic products and new branded drugs. Sponsored by: Oracle Health Sciences New infographic shows trends in clinical development and the impact on randomization and trial supply management technology (RTSM). Sponsored by: Veeva Reduce the effort to create submissions and track registrations with a move to unified RIM. Watch the on-demand webinar. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. | 